4/A//SEC Filing
DHILLON AVTAR S 4/A
Accession 0001144204-18-039106
CIK 0001537561other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 1:13 PM ET
Size
6.2 KB
Accession
0001144204-18-039106
Insider Transaction Report
Form 4/AAmended
DHILLON AVTAR S
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2018-07-19+220,000→ 220,000 totalExercise: $0.42Exp: 2028-07-18→ Common Stock (220,000 underlying)
Footnotes (3)
- [F1]The Amount or Number of shares of Common Stock listed in Column 7 of the reporting person's original Form 4 was inadvertently listed as "200,000".
- [F2]The grants reported on this Statement of Changes in Beneficial Ownership on Form 4 were made in connection with that certain letter agreement dated July 19, 2018 by and between the reporting person and Arch Therapeutics, Inc. (the "Company") pursuant to which the reporting person was engaged as an advisor to the Company. The reporting person resigned from his position as a director of the Company effective as of 4:00 PM Eastern Time.
- [F3]Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date.
Documents
Issuer
Arch Therapeutics, Inc.
CIK 0001537561
Entity typeother
Related Parties
1- filerCIK 0001260933
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 1:13 PM ET
- Size
- 6.2 KB